How semaglutide works as a GLP-1 receptor agonist Semaglutide is a synthetic analogue of human glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the gut after eating
The TRIUMPH program includes multiple phase 3 trials, and one trial, TRIUMPH-Outcomes, is specifically designed to answer the question of whether retatrutide reduces major adverse cardiovascular events
Third, we organize workshops involving different groups of people to analyze the impact of these designer-led regeneration practices on the collective memory of the Tongxing community, and their significance and future potential
Excessive sodium increases blood pressure and glomerular workload, while too little can disrupt electrolyte balance
9 When a carnitine deficiency develops, long-chain fatty acids are not available for -oxidation and energy production, thereby causing excessive lipid accumulation in skeletal muscle, heart, and liver and ultimately, leading to cardiac myopathy and hepatomegaly
Plant-based proteins such as legumes, nuts, and seeds are nutritious but contain more fiber and volume per gram of protein, which can trigger nausea or early fullness when appetite is already suppressed